Timothy H. Self, PharmD; Samantha Ellingson, PharmD, BCPS
When considering potential drug interactions with statin therapy, it is important to consider the hepatic pathways that could be negatively impacted with the addition of new medications.
John Chin, MD, MBChB; Daniel Seidensticker, MD; Andrew Lin, MD
A 44-year-old man with a history of paroxysmal atrial fibrillation (PAF) and New York Heart Association (NYHA) class III heart failure with a reduced ejection fraction (HFrEF) was admitted to our hospital...
Occasionally, the sudden drop in parathyroid hormone levels and subsequent influx of minerals into bone lead to a condition known as hungry bone syndrome.
